Morgan Stanley
VVOS icon

Morgan Stanley’s Vivos Therapeutics VVOS Stock Holding History

Morgan Stanley’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8 Hold
7
– – ﹤0.01% 8224
2025
Q4 		$14 Sell
7
-1,058
-99% -$2.62K ﹤0.01% 8122
2025
Q3 		$3.3K Hold
1,065
– – ﹤0.01% 7194
2025
Q2 		$3.37K Sell
1,065
-249
-19% -$629 ﹤0.01% 7130
2025
Q1 		$3.75K Buy
1,314
+1,240
+1,676% +$4.87K ﹤0.01% 7057
2024
Q4 		$317 Hold
74
– – ﹤0.01% 7377
2024
Q3 		$193 Buy
74
+6
+9% +$16 ﹤0.01% 7388
2024
Q2 		$151 Buy
68
+1
+1% +$2 ﹤0.01% 7313
2024
Q1 		$324 Sell
67
-67
-50% -$400 ﹤0.01% 7273
2023
Q4 		$1.67K Buy
134
+67
+100% +$575 ﹤0.01% 7154
2023
Q3 		$320 Hold
67
– – ﹤0.01% 7353
2023
Q2 		$850 Buy
67
+11
+20% +$108 ﹤0.01% 7322
2023
Q1 		$478 Hold
56
– – ﹤0.01% 7443
2022
Q4 		$563 Hold
56
– – ﹤0.01% 7544
2022
Q3 		$1K Sell
56
-40
-42% -$1.22K ﹤0.01% 7614
2022
Q2 		$3K Sell
96
-49
-34% -$2.04K ﹤0.01% 7531
2022
Q1 		$9K Buy
145
+49
+51% +$3.2K ﹤0.01% 7446
2021
Q4 		$5K Sell
96
-5
-5% -$403 ﹤0.01% 7656
2021
Q3 		$10K Buy
101
+42
+71% +$4.41K ﹤0.01% 7333
2021
Q2 		$7K Buy
59
+39
+195% +$6.35K ﹤0.01% 7328
2021
Q1 		$3K Sell
20
-20
-50% -$3.57K ﹤0.01% 7224
2020
Q4 		$6K Buy
+40
New +$7.3K ﹤0.01% 6750

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Morgan Stanley's VVOS Position: Q1 2026 in Review

Morgan Stanley held its Vivos Therapeutics (VVOS) position steady in Q1 2026 at 7 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #8224.

Morgan Stanley first reported a position in VVOS in Q4 2020 and has held it in 22 quarters since. The position peaked at $10K in Q3 2021. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • Morgan Stanley held 7 shares of Vivos Therapeutics worth $8 as of Q1 2026.
  • Morgan Stanley left its Vivos Therapeutics share count unchanged in Q1 2026.
  • Vivos Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8224 holding.
  • Morgan Stanley first reported a position in Vivos Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Morgan Stanley's Vivos Therapeutics position peaked at $10K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.